By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2....
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2....
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 translating into a market capitalization of USD 45,835 mil. Si...
| Profit Statement | 2017 | 2018 | 2019 | |
| Sales | USD mil | 120,453 | 134,590 | 137,412 |
| Gross Profit | USD mil | 29,387 | 31,092 | 29,698 |
| EBITDA | USD mil | 7,074 | 7,994 | 7,312 |
| EBIT | USD mil | 5,423 | 6,150 | 4,472 |
| Financing Cost | USD mil | 669 | 628 | 709 |
| Pre-Tax Profit | USD mil | 4,614 | 6,204 | 4,144 |
| Net Profit | USD mil | 3,845 | 5,326 | 3,703 |
| Dividends | USD mil | 1,639 | 1,645 | 1,626 |
| Balance Sheet | 2017 | 2018 | 2019 | |
| Total Assets | USD mil | 66,618 | 69,941 | 90,807 |
| Non-Current Assets | USD mil | 46,937 | 49,858 | 71,203 |
| Current Assets | USD mil | 19,681 | 20,083 | 19,604 |
| Working Capital | USD mil | 3,298 | 3,460 | 2,570 |
| Shareholders' Equity | USD mil | 26,756 | 26,263 | 24,313 |
| Liabilities | USD mil | 39,862 | 43,678 | 66,494 |
| Total Debt | USD mil | 14,005 | 15,990 | 42,055 |
| Net Debt | USD mil | 12,175 | 15,010 | 41,244 |
| Ratios | 2017 | 2018 | 2019 | |
| ROE | % | 13.6 | 20.1 | 14.6 |
| ROCE | % | 7.67 | 10.3 | 5.83 |
| Gross Margin | % | 24.4 | 23.1 | 21.6 |
| EBITDA Margin | % | 5.87 | 5.94 | 5.32 |
| EBIT Margin | % | 4.50 | 4.57 | 3.25 |
| Net Margin | % | 3.19 | 3.96 | 2.69 |
| Net Debt/EBITDA | 1.72 | 1.88 | 5.64 | |
| Net Debt/Equity | % | 45.5 | 57.2 | 170 |
| Cost of Financing | % | 4.07 | 4.19 | 2.44 |
| Valuation | 2017 | 2018 | 2019 | |
| Market Capitalisation | USD mil | 83,444 | 65,278 | 45,835 |
| Enterprise Value (EV) | USD mil | 95,619 | 80,288 | 87,079 |
| Number Of Shares | mil | 1,079 | 995 | 924 |
| Share Price | USD | 75.2 | 64.8 | 49.8 |
| EV/EBITDA | 13.5 | 10.0 | 11.9 | |
| EV/Sales | 0.794 | 0.597 | 0.634 | |
| Price/Earnings (P/E) | 19.9 | 12.8 | 11.6 | |
| Price/Book Value (P/BV) | 3.03 | 2.46 | 1.89 | |
| Dividend Yield | % | 2.03 | 2.53 | 3.57 |
Get all company financials in excel:
| overview | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||||||||||||||||||
| Sales | USD mil | 73,230 | 77,617 | 112,923 | 116,819 | 120,453 | ||||||||||||||||||||||
| Gross Profit | USD mil | 21,172 | 21,713 | 28,977 | 29,571 | 29,387 | ||||||||||||||||||||||
| EBIT | USD mil | 3,668 | 3,644 | 4,981 | 5,926 | 5,423 | ||||||||||||||||||||||
| Net Profit | USD mil | 2,732 | 2,067 | 4,480 | 4,117 | 3,845 | ||||||||||||||||||||||
| ROE | % | 14.2 | 10.1 | 17.3 | 13.5 | 13.6 | ||||||||||||||||||||||
| EBIT Margin | % | 5.01 | 4.69 | 4.41 | 5.07 | 4.50 | ||||||||||||||||||||||
| Net Margin | % | 3.73 | 2.66 | 3.97 | 3.52 | 3.19 | ||||||||||||||||||||||
| Employees | 175,000 | 245,000 | 240,000 | 354,000 | 354,000 | ... | ||||||||||||||||||||||
| balance sheet | ||||||||||||||||||||||||||||
| Total Assets | USD mil | 36,481 | 48,612 | 68,657 | 71,912 | 66,618 | ||||||||||||||||||||||
| Non-Current Assets | USD mil | 24,759 | 25,332 | 48,426 | 45,244 | 46,937 | ||||||||||||||||||||||
| Current Assets | USD mil | 11,722 | 23,280 | 20,231 | 26,668 | 19,681 | ||||||||||||||||||||||
| Shareholders' Equity | USD mil | 20,056 | 20,767 | 31,154 | 29,692 | 26,756 | ||||||||||||||||||||||
| Liabilities | USD mil | 16,425 | 27,845 | 37,503 | 42,220 | 39,862 | ||||||||||||||||||||||
| Non-Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Current Liabilities | USD mil | 8,821 | 9,877 | 16,874 | 17,729 | 20,517 | ||||||||||||||||||||||
| Net Debt/EBITDA | 0.826 | 0.337 | 1.73 | 1.04 | 1.72 | |||||||||||||||||||||||
| Net Debt/Equity | % | 20.5 | 8.04 | 37.6 | 31.2 | 45.5 | ||||||||||||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | 3.58 | 1.80 | 4.95 | 3.95 | 4.07 | ||||||||||||||||||
| cash flow | ||||||||||||||||||||||||||||
| Total Cash From Operations | USD mil | 3,833 | 4,791 | 5,365 | 12,829 | 7,729 | ||||||||||||||||||||||
| Total Cash From Investing | USD mil | -2,112 | -861 | -4,492 | -5,118 | -1,531 | ||||||||||||||||||||||
| Total Cash From Financing | USD mil | -2,581 | 7,972 | -11,017 | -213 | -14,013 | ||||||||||||||||||||||
| Net Change In Cash | USD mil | -860 | 11,892 | -10,291 | 7,319 | -7,721 | ||||||||||||||||||||||
| valuation | ||||||||||||||||||||||||||||
| Market Capitalisation | USD mil | 45,503 | 57,517 | 94,332 | 87,408 | 83,444 | ||||||||||||||||||||||
| Enterprise Value (EV) | USD mil | 49,606 | 59,186 | 106,039 | 96,682 | 95,619 | ||||||||||||||||||||||
| Number Of Shares | mil | 955 | 965 | 1,054 | 1,091 | 1,079 | ||||||||||||||||||||||
| Share Price | USD | 41.2 | 52.9 | 77.0 | 73.1 | 75.2 | ||||||||||||||||||||||
| Price/Earnings (P/E) | 16.1 | 26.5 | 19.2 | 19.1 | 19.9 | |||||||||||||||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 10.8 | 18.0 | 13.9 | 14.6 | 15.5 | ||||||||||
| EV/EBITDA | 9.98 | 12.0 | 15.6 | 10.8 | 13.5 | |||||||||||||||||||||||
| Price/Book Value (P/BV) | 1.96 | 2.46 | 2.60 | 2.69 | 3.03 | |||||||||||||||||||||||
| Dividend Yield | % | 2.77 | 2.42 | 1.78 | 1.99 | 2.03 |
| income statement | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||||||||||||||||||
| Sales | USD mil | 73,230 | 77,617 | 112,923 | 116,819 | 120,453 | ||||||||||||||||||||||
| Cost of Goods & Services | USD mil | 52,058 | 55,904 | 83,946 | 87,248 | 91,066 | ||||||||||||||||||||||
| Gross Profit | USD mil | 21,172 | 21,713 | 28,977 | 29,571 | 29,387 | ||||||||||||||||||||||
| Selling, General & Admin | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 17,524 | 18,069 | 23,996 | 23,645 | 23,964 | ||||||||||||
| Research & Development | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||||
| Other Operating Expense | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -20.0 | 0 | 0 | 0 | 0 | ||||||
| Other Operating Cost (Income) | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||
| EBITDA | USD mil | 4,970 | 4,947 | 6,786 | 8,952 | 7,074 | ||||||||||||||||||||||
| Depreciation | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 910 | 768 | 1,342 | 1,337 | 1,401 | |||||||||
| EBIT | USD mil | 3,668 | 3,644 | 4,981 | 5,926 | 5,423 | ||||||||||||||||||||||
| Net Financing Cost | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 169 | 170 | 688 | 631 | 669 | ||||||||||
| Financing Cost | USD mil | ... | ... | 205 | 176 | 713 | 655 | 669 | ||||||||||||||||||||
| Financing Income | USD mil | ... | ... | ... | ... | ... | ... | 36.0 | 6.00 | 25.0 | 24.0 | 0 | ||||||||||||||||
| FX (Gain) Loss | USD mil | 0 | 0 | 0 | 0 | 0 | ... | |||||||||||||||||||||
| (Income) / Loss from Affiliates | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -491 | -639 | -101 | -54.0 | -6.00 | ||
| Extraordinary Cost | USD mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| Pre-Tax Profit | USD mil | 4,335 | 3,606 | 5,386 | 5,146 | 4,614 | ||||||||||||||||||||||
| Tax | USD mil | 1,594 | 1,422 | 902 | 1,050 | 767 | ||||||||||||||||||||||
| Minorities | USD mil | ... | 9.00 | 117 | 39.0 | 24.0 | 11.0 | |||||||||||||||||||||
| Net Profit | USD mil | 2,732 | 2,067 | 4,480 | 4,117 | 3,845 | ||||||||||||||||||||||
| Net Profit Avail. to Common | USD mil | 2,732 | 2,067 | 4,480 | 4,117 | 3,845 | ||||||||||||||||||||||
| Dividends | USD mil | 1,121 | 1,245 | 1,507 | 1,590 | 1,639 | ||||||||||||||||||||||
| growth rates | ||||||||||||||||||||||||||||
| Total Revenue Growth | % | ... | 3.44 | 5.99 | 45.5 | 3.45 | 3.11 | |||||||||||||||||||||
| Operating Cost Growth | % | ... | 2.53 | 3.23 | 32.8 | -1.46 | 1.35 | |||||||||||||||||||||
| EBITDA Growth | % | ... | 11.3 | -0.463 | 37.2 | 31.9 | -21.0 | |||||||||||||||||||||
| EBIT Growth | % | ... | 12.3 | -0.654 | 36.7 | 19.0 | -8.49 | |||||||||||||||||||||
| Pre-Tax Profit Growth | % | ... | 37.1 | -16.8 | 49.4 | -4.46 | -10.3 | |||||||||||||||||||||
| Net Profit Growth | % | ... | 37.6 | -24.3 | 117 | -8.10 | -6.61 | |||||||||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| ROE | % | 14.2 | 10.1 | 17.3 | 13.5 | 13.6 | ||||||||||||||||||||||
| ROA | % | 7.62 | 4.86 | 7.64 | 5.86 | 5.55 | ||||||||||||||||||||||
| ROCE | % | 9.29 | 6.81 | 10.6 | 7.88 | 7.67 | ||||||||||||||||||||||
| Gross Margin | % | 28.9 | 28.0 | 25.7 | 25.3 | 24.4 | ||||||||||||||||||||||
| EBITDA Margin | % | 6.79 | 6.37 | 6.01 | 7.66 | 5.87 | ||||||||||||||||||||||
| EBIT Margin | % | 5.01 | 4.69 | 4.41 | 5.07 | 4.50 | ||||||||||||||||||||||
| Net Margin | % | 3.73 | 2.66 | 3.97 | 3.52 | 3.19 | ||||||||||||||||||||||
| Payout Ratio | % | 41.0 | 60.2 | 33.6 | 38.6 | 42.6 | ||||||||||||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | 3.58 | 1.80 | 4.95 | 3.95 | 4.07 | ||||||||||||||||||
| Net Debt/EBITDA | 0.826 | 0.337 | 1.73 | 1.04 | 1.72 |
| balance sheet | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| balance sheet | ||||||||||||||||||||||||||||
| Cash & Cash Equivalents | USD mil | 969 | 12,861 | 2,570 | 9,598 | 1,830 | ||||||||||||||||||||||
| Receivables | USD mil | 2,727 | 3,579 | 6,821 | 6,138 | 6,858 | ||||||||||||||||||||||
| Inventories | USD mil | 7,729 | 6,518 | 9,884 | 10,039 | 10,010 | ||||||||||||||||||||||
| Other ST Assets | USD mil | 297 | 322 | 956 | 893 | 983 | ||||||||||||||||||||||
| Current Assets | USD mil | 11,722 | 23,280 | 20,231 | 26,668 | 19,681 | ||||||||||||||||||||||
| Property, Plant & Equipment | USD mil | 12,351 | 12,103 | 14,878 | 13,709 | 13,693 | ||||||||||||||||||||||
| LT Investments & Receivables | USD mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
| Intangible Assets | USD mil | 5,107 | 4,598 | 28,235 | 24,931 | 26,519 | ||||||||||||||||||||||
| Goodwill | USD mil | 2,491 | 2,356 | 16,195 | 15,203 | 15,931 | ||||||||||||||||||||||
| Non-Current Assets | USD mil | 24,759 | 25,332 | 48,426 | 45,244 | 46,937 | ||||||||||||||||||||||
| Total Assets | USD mil | 36,481 | 48,612 | 68,657 | 71,912 | 66,618 | ||||||||||||||||||||||
| Trade Payables | USD mil | 4,762 | 5,189 | 10,643 | 11,372 | 13,570 | ||||||||||||||||||||||
| Short-Term Debt | USD mil | 571 | 774 | 1,083 | 1,095 | 1,268 | ||||||||||||||||||||||
| Other ST Liabilities | USD mil | 0 | 96.0 | 0 | 0 | 15.0 | ||||||||||||||||||||||
| Current Liabilities | USD mil | 8,821 | 9,877 | 16,874 | 17,729 | 20,517 | ||||||||||||||||||||||
| Long-Term Debt | USD mil | 4,501 | 13,756 | 13,194 | 17,777 | 12,737 | ||||||||||||||||||||||
| Other LT Liabilities | USD mil | 3,519 | 4,378 | 7,619 | 6,885 | 6,772 | ||||||||||||||||||||||
| Non-Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Liabilities | USD mil | 16,425 | 27,845 | 37,503 | 42,220 | 39,862 | ||||||||||||||||||||||
| Preferred Equity and Hybrid Capital | USD mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
| Share Capital | USD mil | 1,133 | 1,259 | 10,009 | 10,144 | 10,371 | ||||||||||||||||||||||
| Treasury Stock | USD mil | 3,042 | 3,558 | 4,446 | 5,341 | 12,459 | ||||||||||||||||||||||
| Equity Before Minority Interest | USD mil | 20,021 | 20,636 | 30,709 | 29,325 | 25,929 | ||||||||||||||||||||||
| Minority Interest | USD mil | 35.0 | 131 | 445 | 367 | 827 | ||||||||||||||||||||||
| Equity | USD mil | 20,056 | 20,767 | 31,154 | 29,692 | 26,756 | ||||||||||||||||||||||
| growth rates | ||||||||||||||||||||||||||||
| Total Asset Growth | % | ... | 3.47 | 33.3 | 41.2 | 4.74 | -7.36 | |||||||||||||||||||||
| Shareholders' Equity Growth | % | ... | 9.12 | 3.55 | 50.0 | -4.69 | -9.89 | |||||||||||||||||||||
| Net Debt Growth | % | ... | -9.94 | -59.3 | 601 | -20.8 | 31.3 | |||||||||||||||||||||
| Total Debt Growth | % | ... | ... | ... | ... | ... | ... | -20.6 | 186 | -1.74 | 32.2 | -25.8 | ||||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| Total Debt | USD mil | 5,072 | 14,530 | 14,277 | 18,872 | 14,005 | ||||||||||||||||||||||
| Net Debt | USD mil | 4,103 | 1,669 | 11,707 | 9,274 | 12,175 | ||||||||||||||||||||||
| Working Capital | USD mil | 5,694 | 4,908 | 6,062 | 4,805 | 3,298 | ||||||||||||||||||||||
| Capital Employed | USD mil | 30,453 | 30,240 | 54,488 | 50,049 | 50,235 | ||||||||||||||||||||||
| Net Debt/Equity | % | 20.5 | 8.04 | 37.6 | 31.2 | 45.5 | ||||||||||||||||||||||
| Current Ratio | 1.33 | 2.36 | 1.20 | 1.50 | 0.959 | |||||||||||||||||||||||
| Quick Ratio | 0.419 | 1.66 | 0.557 | 0.888 | 0.423 |
| cash flow | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| cash flow | ||||||||||||||||||||||||||||
| Net Profit | USD mil | 2,732 | 2,067 | 4,480 | 4,117 | 3,845 | ||||||||||||||||||||||
| Depreciation | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 910 | 768 | 1,342 | 1,337 | 1,401 | |||||||||
| Non-Cash Items | USD mil | -150 | 246 | -333 | 942 | 168 | ||||||||||||||||||||||
| Change in Working Capital | USD mil | -51.0 | 1,175 | -587 | 1,601 | 2,065 | ||||||||||||||||||||||
| Total Cash From Operations | USD mil | 3,833 | 4,791 | 5,365 | 12,829 | 7,729 | ||||||||||||||||||||||
| Capital Expenditures | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -1,091 | -1,102 | -1,035 | -2,010 | -1,305 | ||||||
| Net Change in LT Investment | USD mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| Net Cash From Acquisitions | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -382 | 620 | -3,775 | 156 | -250 | ||||||
| Other Investing Activities | USD mil | -639 | -379 | 318 | -3,264 | 24.0 | ||||||||||||||||||||||
| Total Cash From Investing | USD mil | -2,112 | -861 | -4,492 | -5,118 | -1,531 | ||||||||||||||||||||||
| Dividends Paid | USD mil | -1,078 | -1,223 | -1,455 | -2,750 | -1,730 | ||||||||||||||||||||||
| Issuance Of Shares | USD mil | -156 | -284 | -793 | -1,852 | -7,080 | ||||||||||||||||||||||
| Issuance Of Debt | USD mil | -1,300 | 242 | -8,422 | 3,879 | -5,164 | ||||||||||||||||||||||
| Other Financing Activities | USD mil | -47.0 | -94.0 | -347 | -185 | -39.0 | ||||||||||||||||||||||
| Total Cash From Financing | USD mil | -2,581 | 7,972 | -11,017 | -213 | -14,013 | ||||||||||||||||||||||
| Effect of FX Rates | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | -29.8 | -147 | -179 | 94.0 | ||||||
| Net Change In Cash | USD mil | -860 | 11,892 | -10,291 | 7,319 | -7,721 | ||||||||||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| Days Sales Outstanding | days | 13.6 | 16.8 | 22.0 | 19.2 | 20.8 | ||||||||||||||||||||||
| Days Sales Of Inventory | days | 54.2 | 42.6 | 43.0 | 42.0 | 40.1 | ||||||||||||||||||||||
| Days Payable Outstanding | days | 33.4 | 33.9 | 46.3 | 47.6 | 54.4 | ||||||||||||||||||||||
| Cash Conversion Cycle | days | 34.4 | 25.5 | 18.7 | 13.6 | 6.51 | ||||||||||||||||||||||
| Cash Earnings | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3,642 | 2,835 | 5,822 | 5,454 | 5,246 | |||||||||
| Free Cash Flow | USD mil | 1,721 | 3,930 | 873 | 7,711 | 6,198 | ||||||||||||||||||||||
| Capital Expenditures (As % of Sales) | % | 1.49 | 1.42 | 0.917 | 1.72 | 1.08 |
| other ratios | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Employees | 175,000 | 245,000 | 240,000 | 354,000 | 354,000 | ... | ||||||||||||||||||||||
| Employee Turnover | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 32.0 | 21.0 | 21.0 | ... | |
| Women (As % of Workforce) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 65.2 | ... | 66.0 | 66.0 | 67.0 | ... | ||
| Operating Cost (As % of Sales) | % | 23.9 | 23.3 | 21.2 | 20.2 | 19.9 | ||||||||||||||||||||||
| Research & Development (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||||
| Effective Tax Rate | % | 36.8 | 39.4 | 16.7 | 20.4 | 16.6 | ||||||||||||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 4.08 | 3.69 | 10.5 | 9.86 | 11.2 | |||||||||||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 8.05 | 7.21 | 10.1 | 9.03 | 8.14 |
| valuation | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Market Capitalisation | USD mil | 45,503 | 57,517 | 94,332 | 87,408 | 83,444 | ||||||||||||||||||||||
| Enterprise Value (EV) | USD mil | 49,606 | 59,186 | 106,039 | 96,682 | 95,619 | ||||||||||||||||||||||
| Number Of Shares | mil | 955 | 965 | 1,054 | 1,091 | 1,079 | ||||||||||||||||||||||
| Share Price | USD | 41.2 | 52.9 | 77.0 | 73.1 | 75.2 | ||||||||||||||||||||||
| EV/EBITDA | 9.98 | 12.0 | 15.6 | 10.8 | 13.5 | |||||||||||||||||||||||
| Price/Earnings (P/E) | 16.1 | 26.5 | 19.2 | 19.1 | 19.9 | |||||||||||||||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 10.8 | 18.0 | 13.9 | 14.6 | 15.5 | ||||||||||
| P/FCF | 22.9 | 13.0 | 92.9 | 10.3 | 13.1 | |||||||||||||||||||||||
| Price/Book Value (P/BV) | 1.96 | 2.46 | 2.60 | 2.69 | 3.03 | |||||||||||||||||||||||
| Dividend Yield | % | 2.77 | 2.42 | 1.78 | 1.99 | 2.03 | ||||||||||||||||||||||
| Free Cash Flow Yield | % | 3.78 | 6.83 | 0.925 | 8.82 | 7.43 | ||||||||||||||||||||||
| Earnings Per Share (EPS) | USD | 2.56 | 2.00 | 4.00 | 3.82 | 3.78 | ||||||||||||||||||||||
| Cash Earnings Per Share | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3.81 | 2.94 | 5.52 | 5.00 | 4.86 | |||||||||
| Free Cash Flow Per Share | USD | 1.80 | 4.07 | 0.828 | 7.07 | 5.75 | ||||||||||||||||||||||
| Book Value Per Share | USD | 21.0 | 21.5 | 29.6 | 27.2 | 24.8 | ||||||||||||||||||||||
| Dividend Per Share | USD | 1.14 | 1.28 | 1.37 | 1.46 | 1.53 | ||||||||||||||||||||||
| EV/Sales | 0.677 | 0.763 | 0.939 | 0.828 | 0.794 | |||||||||||||||||||||||
| EV/EBIT | 13.5 | 16.2 | 21.3 | 16.3 | 17.6 | |||||||||||||||||||||||
| EV/Free Cash Flow | 28.8 | 15.1 | 121 | 12.5 | 15.4 | |||||||||||||||||||||||
| EV/Capital Employed | 1.63 | 1.96 | 1.95 | 1.93 | 1.90 | |||||||||||||||||||||||
| Earnings Per Share Growth | % | ... | 5.79 | -21.9 | 100 | -4.50 | -1.05 | |||||||||||||||||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 20.3 | -23.0 | 88.1 | -9.51 | -2.69 | |||||||
| Book Value Per Share Growth | % | ... | 0.545 | 2.47 | 37.4 | -7.94 | -8.84 |
Get all company financials in excel:
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 translating into a market capitalization of USD 45,835 mil. Since the end of 2014, stock has depreciated by 5.88% representing an annual average growth of -1.20%. In absolute terms, the ...
By Helgi Library - August 11, 2020
Walgreens Boots's net debt stood at USD 41,244 mil and accounted for 170% of equity at the end of 2019. The ratio is up 112 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 170% in 2019 and a low of ...
By Helgi Library - August 11, 2020
Walgreens Boots's net debt stood at USD 41,244 mil and accounted for 170% of equity at the end of 2019. The ratio is up 112 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 170% in 2019 and a low of ...
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil in 2019, down 30.5% compared to the previous year. Historically, between 1993 and 2019, the company's net profit reached a high of USD 5,326 mil in 2018 and a low of USD 226 mil in 1993. The result implie...
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil in 2019, down 30.5% compared to the previous year. Historically, between 1993 and 2019, the company's net profit reached a high of USD 5,326 mil in 2018 and a low of USD 226 mil in 1993. The result implie...
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2.10%, respectively, compared to the previous year. This translates into a net margin of 2.69%. Historically, between 1993 and 2019, ...
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2.10%, respectively, compared to the previous year. This translates into a net margin of 2.69%. Historically, between 1993 and 2019, ...
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 implying a market capitalization of USD 45,835 mil. Since the end of 2014, stock has appreciated by -5.88% implying an annual average growth of -1.20% In absolute terms, the value of the company ...
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 translating into a market capitalization of USD 45,835 mil. Since the end of 2014, the stock has depreciated by 5.88% representing an annual average growth of -1.20%. At the end of 2019, ...
By Helgi Library - August 11, 2020
Walgreens Boots invested a total of USD 1,510 mil in 2019, up 91.9% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of USD 2,010 mil in 2016 and a low of USD 787 mil in 2018. ...
Walgreens Boots Alliance is a pharmacy-led health and wellbeing company. It operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general goods. The Company also offers health services, including primary and acute care, wellness, pharmacy and disease management services, and health and fitness. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Botanics, Sleek MakeUP and YourGoodSkin.
Walgreens Boots has been growing its sales by 12.1% a year on average in the last 5 years. EBITDA has grown on average by 8.130000000000001% a year during that time to total of USD 7,312 mil in 2019, or 5.32% of sales. That’s compared to 6.16% average margin seen in last five years.
The company netted USD 3,703 mil in 2019 implying ROE of 14.6% and ROCE of 5.83%. Again, the average figures were 15.8% and 8.45%, respectively when looking at the previous 5 years.
Walgreens Boots’s net debt amounted to USD 41,244 mil at the end of 2019, or 170% of equity. When compared to EBITDA, net debt was 5.64x, up when compared to average of 2.40x seen in the last 5 years.
Walgreens Boots stock traded at USD 49.8 per share at the end of 2019 resulting in a market capitalization of USD 45,835 mil. Over the previous five years, stock price fell by 5.88% or -1.20% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 11.9x and price to earnings (PE) of 11.6x as of 2019.
Helgi Library 
